Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nervabin Plus
- Development stage
- Unknown
- Lead developer
- Wonne International
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Nervabin Plus is an oral neuroprotective combination capsule developed by Wonne International. It contains methylcobalamin (vitamin B12), alpha lipoic acid, thiamine (vitamin B1), pyridoxine (vitamin B6), and folic acid (vitamin B9). This formulation is designed to support nerve health, promote myelin sheath regeneration, and reduce oxidative stress. It is primarily indicated for the management of diabetic neuropathy, peripheral neuropathy, and nutritional deficiencies.
- Brand names
- Nervabin PlusNervabin-Plus
- Other names
- methylcobalamin + alpha lipoic acid + thiamine + pyridoxine + folic acidmethylcobalamin + alpha lipoic acid + thiamine + pyridoxine hydrochloride + folic acidmethylcobalamin + alpha lipoic acid + vitamin B1 + vitamin B6 + folic acidmethylcobalamin + alpha lipoic acid + vitamin B1 + vitamin B6 + vitamin B9
02
Targets
MTR (Methionine synthase)DHFR (Dihydrofolate reductase)OGDH (Dihydrolipoamide S-succinyltransferase)PDXK (Pyridoxal kinase)PNPO (Pyridoxine 5'-phosphate oxidase)PDH (Pyruvate dehydrogenase complex)TPK1 (Thiamine pyrophosphokinase 1)
Beyond the preview
Go deeper on Nervabin Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nervabin Plus.